CXCR4 expression on the surface of bone marrow mesenchymal stem cells in chronic liver failure environment and the influential factors

Xiao-ping Huang,Ai-lan Qin,Wei-feng Zhao,Min-hua Jiang,Er-ping Luo,Shao-hong Wu,Jian-he Gan
DOI: https://doi.org/10.3969/j.issn.1673-8225.2009.40.016
2009-01-01
Abstract:BACKGROUND: Only a small proportion of bone marrow mesenchymal stem cells (BMSCs) express functionally active CXCR4. We hypothesized the possibility that environment of severe liver failure may up-regulate CXCR4 on the surface of BMSCs, enhance homing of BMSCs towards the liver, and participate in liver regeneration. OBJECTIVE: To investigate the effects of body fluid environment on CXCR4 expression on the surface of human BMSCs in chronic liver function failure patients. DESIGN, TIME AND SETTING: The cytological in vitro controlled experiment was performed at the Laboratory of the Infectious Disease Department, First Affiliated Hospital, Soochow University from January 2007 to October 2008. PARTICIPANTS: Bone marrow and normal plasma samples were collected from healthy volunteers, and plasma of patients was harvested from a chronic liver failure patient, who was hospitalized. The patient signed the informed consent. METHODS: BMSCs was isolated from healthy donors and cultured with cell culture technique. BMSCs were stimulated with plasma from patient with chronic liver failure, plasma from healthy donor, interleukin-6, endotoxin or tumor necrosis factor-alpha for respectively 48 hours. Plasma from normal person and medium served as controls. MAIN OUTCOME MEASURES: Cell-surface expression of CXCR4 was assessed by flow cytometry in each group. RESULTS: The expression of CXCR4 of BMSCs in groups stimulated with plasma from patient with chronic liver failure for 48 hours, endotoxin and interkeukin-6 was (28.03±0.45)%, (14.17±0.47)% and (17.07±0.40)%, respectively. In culture media, the expression of CXCR4 was (9.20±0.46)%, there was significant difference of three stimulated groups to the control group (P < 0.05). The expression of CXCR4 on the surface of BMSCs stimulated with tumor necrosis factor-alpha and in plasma from healthy donors was (9.17±0.31)% and (8.77±0.45)%, respectively. It was significant difference compared with the control group (P > 0.05). CONCLUSION: CXCR4 expression on the surface of BMSCs from patients with chronic liver failure is significantly enhanced, and Endotoxin and interleukin-6 may be important stimulating factors in this procedure.
What problem does this paper attempt to address?